Glaxosmithkline Plc (GSK)
$38.47 0.31 (0.81%)
19:51 EST GSK Stock Quote Delayed 30 Minutes
Previous Close -
Market Cap 95.40B
PE Ratio 92.48
Volume (Avg. Vol.) 3.10M
Day's Range 38.21 - 38.66
52-Week Range 31.43 - 48.25
Dividend & Yield 2.14 (5.56%)
GSK Stock Predictions, Articles, and Glaxosmithkline Plc News
- From InvestorPlace
- From the Web
As the Covid-19 pandemic worsens, the case for dental stocks to buy might not seem too bright. However, this sector is a very broad one, with upside opportunities available right now.
Buying strong vaccine stocks at the forefront of the scientific race to treat Covid-19 will help any long-term portfolio in 2021.
GlaxoSmithKline and Sanofi stock are rallying in early trading on Friday thanks to news they would supply the EU 300 million vaccine doses.
By Thomas Niel
Whether or not we get an 'October Surprise' from President Donald Trump, these coronavirus vaccine stocks look hot now. AstraZeneca (NYSE:AZN) CureVac (NASDAQ:CVAC) GlaxoSmithKline (NYSE:GSK) Inovio (NASDAQ:INO) Johnson & Johnson (NYSE:JNJ) Moderna (NASDAQ:MRNA) Novavax (NASDAQ:NVAX)
Although broader markets may continue to be volatilie in the rest of the year, these five hot stocks to buy should be on your shopping list.
As the market continues to deal with the pandemic, these five cheap drug stocks have solid dividend yields of 4% and almost 37% upside.
Friday's big stock charts feature pharmaceutical-market names that recently posted terrific earnings data.
A number of S&P 500 companies have already increased their 2020 dividends by 10% or more. Here are 10 stocks to buy among this group.
Amarin is targeting a huge market, and its main drug -- Vascepa -- is likely to be expanded in its coverage. Here’s a look at what’s ahead for the stock.
Turning Point Brands, Cronos Group and Altria are just some of the stocks to buy or sell here at a pivotal time for vaporizers.
With international dividend stocks, valuations are generally better and yields are bigger. Here are five stocks that stand out.
These ten stocks aren't exactly household names, but they each deserve a spot in a list of small-cap stocks to buy now for traders that can deal with the risk for the potential of high reward.
Think all blue-chip stocks are safe buys at any time? Think again. These companies may be about to stumble, if they haven't already.
These three biopharma stocks to buy should help investors maintain strength amid any potential chaos in 2019.
GlaxoSmithKline (GSK) stock is up today on news of a new joint venture with Pfizer (PFE) for a consumer healthcare business.
The stock charts of ROST, D and MS are shaping up as the top trading prospects as December's action gets going.
Tesaro stock was flying high on Monday with news that GlaxoSmithKline (GSK) is planning to acquire it in a deal worth $5.10 billion.
If you're looking for the best dividend stocks with high yields and solid growth prospects, don't limit yourself -- look overseas.
These seven healthcare stocks are coming to life Monday. Here's how to play these companies without getting burnt.
From Talk Markets
From Talk Markets
Navellier RatingsPowered by Portfolio Grader